Are you Dr. Lauring?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 38 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
650 W 168th St
Bb-1427 Dept Pathology Columbia University
New York, NY 10032Phone+1 212-305-0395Fax+1 212-305-5498- Is this information wrong?
Summary
- Dr. Brett Lauring, MD is a board certified pathologist in New York, New York. He is currently licensed to practice medicine in New York.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Pathology-Anatomic and Clinical, 1996 - 2001
New York University School of MedicineClass of 1996
Certifications & Licensure
NY State Medical License 1997 - 2021- American Board of Pathology Anatomic Pathology
Publications & Presentations
PubMed
- 34 citationsSafety and efficacy of ertugliflozin in Asian patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: VERTIS Asia.Linong Ji, Yanmei Liu, Heng Miao, Yongli Xie, Ming Yang, Wei Wang, Yuting Mu, Ping Yan, Sharon Pan, Brett Lauring, Shu Liu, Susan Huyck, Yanping Qiu, Steven G. Terra> ;Diabetes, Obesity & Metabolism. 2019 Jun 1
- 40 citationsLong-term efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: 104-week VERTIS MET trial.Silvina Gallo, Bernard Charbonnel, Allison Goldman, Harry Shi, Susan Huyck, Amanda Darekar, Brett Lauring, Steven G. Terra> ;Diabetes, Obesity & Metabolism. 2019 Apr 1
- 24 citationsResults of VERTIS SU extension study: safety and efficacy of ertugliflozin treatment over 104 weeks compared to glimepiride in patients with type 2 diabetes mellitus i...Priscilla Hollander, Julie Hill, Jeremy Johnson, Zhi Wei Jiang, Gregory T. Golm, Susan Huyck, Steven G. Terra, James P. Mancuso, Samuel S. Engel, Brett Lauring, Jie Liu> ;Current Medical Research and Opinion. 2019 Mar 25
- Join now to see all
Press Mentions
Kallyope Inc. Appoints Brett Lauring as Chief Medical OfficerFebruary 5th, 2019
Kallyope to Expand Its Metabolic Disorder Programme GloballyOctober 26th, 2023- Kallyope Enters Phase 2 with First-in-Class Oral Approach for the Treatment of Both Obesity and Type 2 DiabetesSeptember 28th, 2023
